Translations:ENDS Respiratory System/48/en: Difference between revisions

Safer nicotine wiki Tobacco Harm Reduction
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
2,302 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 01:08, 20 November 2021

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (ENDS Respiratory System)
Also, given that the propylene glycol in EC aerosols is a potent bactericidal agent, switching from smoking to regular vaping is likely to produce additional lung health benefits.
In conclusion, smokers who quit by switching to regular ECs use can reduce risk and reverse harm from tobacco smoking. 
Innovation in the e-vapour category is likely not only to further minimise residual health risks, but also to maximise health benefits.

Also, given that the propylene glycol in EC aerosols is a potent bactericidal agent, switching from smoking to regular vaping is likely to produce additional lung health benefits. In conclusion, smokers who quit by switching to regular ECs use can reduce risk and reverse harm from tobacco smoking. Innovation in the e-vapour category is likely not only to further minimise residual health risks, but also to maximise health benefits.

Retrieved from "https://safernicotine.wiki/mediawiki/index.php?title=Translations:ENDS_Respiratory_System/48/en&oldid=11480"